A MECC-Organized Symposium at the ATS 2025 International Conference. An evening symposia educational program sponsored by Med Learning Group and supported by a grant from Boehringer Ingleheim Pharmaceuticals open to all ATS 2025 International Conference attendees.
Saturday, May 17, 2025
7:00 PM – 7:30 PM PST: Registration/Dinner
7:30 PM – 8:30 PM PST: Symposium
San Francisco Marriott Marquis
Meeting Room: Yerba Buena 9 (Lower B2 Level)
780 Mission St
San Francisco, CA
PROGRAM FEATURES
- Interactive, case-based learning environment
- Customize your own personalized poster
PRESENTING FACULTY
![]() |
Nirav G. Shah, MD, FCCP, ATSF Professor of Medicine Assistant Dean for Medical Education Clinical Chief, Division of Pulmonary, Critical Care, & Sleep Medicine University of Maryland School of Medicine Baltimore, MD |
PROGRAM OVERVIEW
This live activity has been designed to help improve learners’ ability to understand the pathophysiology of Fibrosing Interstitial Lung Diseases (F-ILDs), their clinical characteristics, and the burdens associated with F-ILDs. With this updated knowledge, learners will be better equipped with best practices for diagnosing and treating patients with F-ILDs. New and emerging treatment options for F-ILDs will also be discussed, as well as the value of a multidisciplinary approach toward achieving optimal patient outcomes.
TARGET AUDIENCE
This activity is designed to meet the educational needs of pulmonologists.
LEARNING OBJECTIVES
Upon completion of this activity, attendees will have improved ability to:
- Describe F-ILD pathophysiology, clinical characteristics, and burdens
- Utilize best practices for the timely and accurate diagnosis of F-ILD
- Recognize the clinical profiles of new and emerging treatment options for F-ILDs
- Apply multidisciplinary teamwork to the comprehensive management of F-ILDs
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]